JP2014508139A - フラボン系化合物の新規な用途 - Google Patents
フラボン系化合物の新規な用途 Download PDFInfo
- Publication number
- JP2014508139A JP2014508139A JP2013550414A JP2013550414A JP2014508139A JP 2014508139 A JP2014508139 A JP 2014508139A JP 2013550414 A JP2013550414 A JP 2013550414A JP 2013550414 A JP2013550414 A JP 2013550414A JP 2014508139 A JP2014508139 A JP 2014508139A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- perbiflora
- extract
- flavone compounds
- aging
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 title claims abstract description 99
- 229930003944 flavone Natural products 0.000 title claims abstract description 99
- 235000011949 flavones Nutrition 0.000 title claims abstract description 99
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 title claims abstract description 99
- -1 flavone compounds Chemical class 0.000 title claims abstract description 96
- 239000000203 mixture Substances 0.000 claims abstract description 77
- 239000000284 extract Substances 0.000 claims abstract description 65
- 230000037394 skin elasticity Effects 0.000 claims abstract description 57
- 230000037303 wrinkles Effects 0.000 claims abstract description 56
- 230000003712 anti-aging effect Effects 0.000 claims abstract description 45
- 239000004480 active ingredient Substances 0.000 claims abstract description 44
- 230000003020 moisturizing effect Effects 0.000 claims abstract description 31
- 230000002708 enhancing effect Effects 0.000 claims abstract description 22
- 150000003839 salts Chemical class 0.000 claims description 32
- 239000002537 cosmetic Substances 0.000 claims description 31
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 30
- 235000013305 food Nutrition 0.000 claims description 25
- 239000000126 substance Substances 0.000 claims description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- 230000006872 improvement Effects 0.000 claims description 24
- 238000004519 manufacturing process Methods 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 20
- 239000002904 solvent Substances 0.000 claims description 18
- 239000008194 pharmaceutical composition Substances 0.000 claims description 14
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 6
- 239000004909 Moisturizer Substances 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- 230000001333 moisturizer Effects 0.000 claims description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 5
- 239000003623 enhancer Substances 0.000 claims description 5
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 5
- 239000003960 organic solvent Substances 0.000 claims description 5
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 claims description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 4
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 2
- 239000012530 fluid Substances 0.000 claims description 2
- 239000003208 petroleum Substances 0.000 claims description 2
- 150000001298 alcohols Chemical class 0.000 claims 1
- ZGEGCLOFRBLKSE-UHFFFAOYSA-N methylene hexane Natural products CCCCCC=C ZGEGCLOFRBLKSE-UHFFFAOYSA-N 0.000 claims 1
- WPHGSKGZRAQSGP-UHFFFAOYSA-N methylenecyclohexane Natural products C1CCCC2CC21 WPHGSKGZRAQSGP-UHFFFAOYSA-N 0.000 claims 1
- 108010035532 Collagen Proteins 0.000 abstract description 15
- 102000008186 Collagen Human genes 0.000 abstract description 15
- 229920001436 collagen Polymers 0.000 abstract description 15
- 230000037319 collagen production Effects 0.000 abstract description 9
- 108090000790 Enzymes Proteins 0.000 abstract description 7
- 102000004190 Enzymes Human genes 0.000 abstract description 7
- 230000001737 promoting effect Effects 0.000 abstract description 7
- 230000000593 degrading effect Effects 0.000 abstract description 4
- 206010040954 Skin wrinkling Diseases 0.000 abstract 2
- ZXJJBDHPUHUUHD-UHFFFAOYSA-N 4',5,7-Trimethoxyflavone Chemical compound C1=CC(OC)=CC=C1C1=CC(=O)C2=C(OC)C=C(OC)C=C2O1 ZXJJBDHPUHUUHD-UHFFFAOYSA-N 0.000 description 112
- JRFZSUMZAUHNSL-UHFFFAOYSA-N chrysin 5,7-dimethyl ether Chemical compound C=1C(OC)=CC(OC)=C(C(C=2)=O)C=1OC=2C1=CC=CC=C1 JRFZSUMZAUHNSL-UHFFFAOYSA-N 0.000 description 107
- 210000003491 skin Anatomy 0.000 description 88
- ALGDHWVALRSLBT-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-3,5,7-trimethoxychromen-4-one Chemical compound C=1C(OC)=CC(OC)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 ALGDHWVALRSLBT-UHFFFAOYSA-N 0.000 description 78
- IAFBOKYTDSDNHV-UHFFFAOYSA-N (2S)-(-)-5,7-dimethoxyflavanone Natural products O1C2=CC(OC)=CC(OC)=C2C(=O)CC1C1=CC=CC=C1 IAFBOKYTDSDNHV-UHFFFAOYSA-N 0.000 description 53
- 239000000469 ethanolic extract Substances 0.000 description 49
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 45
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 21
- 230000000694 effects Effects 0.000 description 20
- 238000000926 separation method Methods 0.000 description 20
- 239000006210 lotion Substances 0.000 description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- 230000032683 aging Effects 0.000 description 13
- 239000006071 cream Substances 0.000 description 12
- 239000000843 powder Substances 0.000 description 10
- 241000699670 Mus sp. Species 0.000 description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 9
- 239000013543 active substance Substances 0.000 description 9
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- 235000016709 nutrition Nutrition 0.000 description 9
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 9
- 238000011160 research Methods 0.000 description 9
- 239000000741 silica gel Substances 0.000 description 9
- 229910002027 silica gel Inorganic materials 0.000 description 9
- 206010051246 Photodermatosis Diseases 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- 238000002156 mixing Methods 0.000 description 8
- 230000008845 photoaging Effects 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 7
- 238000004440 column chromatography Methods 0.000 description 7
- 238000009472 formulation Methods 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 230000002829 reductive effect Effects 0.000 description 7
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 229940088598 enzyme Drugs 0.000 description 6
- 210000002615 epidermis Anatomy 0.000 description 6
- 238000007429 general method Methods 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- 101150014058 MMP1 gene Proteins 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 108700004333 collagenase 1 Proteins 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 150000002212 flavone derivatives Chemical class 0.000 description 5
- 235000013402 health food Nutrition 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 210000000214 mouth Anatomy 0.000 description 5
- 230000035764 nutrition Effects 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 230000037373 wrinkle formation Effects 0.000 description 5
- 239000001913 cellulose Substances 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 235000010980 cellulose Nutrition 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 210000002950 fibroblast Anatomy 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 3
- 238000005160 1H NMR spectroscopy Methods 0.000 description 3
- SXAMGRAIZSSWIH-UHFFFAOYSA-N 2-[3-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,2,4-oxadiazol-5-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NOC(=N1)CC(=O)N1CC2=C(CC1)NN=N2 SXAMGRAIZSSWIH-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 108060005980 Collagenase Proteins 0.000 description 3
- 102000029816 Collagenase Human genes 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 239000006143 cell culture medium Substances 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000003366 colagenolytic effect Effects 0.000 description 3
- 230000011382 collagen catabolic process Effects 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 235000013312 flour Nutrition 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229930014626 natural product Natural products 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 0 *c(cc1*)cc(OC(c2ccc(*=C)cc2)=C2)c1C2=O Chemical compound *c(cc1*)cc(OC(c2ccc(*=C)cc2)=C2)c1C2=O 0.000 description 2
- VSFZYCDPDWSYSS-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 VSFZYCDPDWSYSS-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 241000395050 Kaempferia parviflora Species 0.000 description 2
- 108010016113 Matrix Metalloproteinase 1 Proteins 0.000 description 2
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 108010050808 Procollagen Proteins 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 230000001153 anti-wrinkle effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 235000015895 biscuits Nutrition 0.000 description 2
- YYRMJZQKEFZXMX-UHFFFAOYSA-L calcium bis(dihydrogenphosphate) Chemical compound [Ca+2].OP(O)([O-])=O.OP(O)([O-])=O YYRMJZQKEFZXMX-UHFFFAOYSA-L 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 229940112822 chewing gum Drugs 0.000 description 2
- 235000015218 chewing gum Nutrition 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 238000011496 digital image analysis Methods 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 239000007903 gelatin capsule Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 235000021067 refined food Nutrition 0.000 description 2
- 150000004492 retinoid derivatives Chemical class 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- ZAIANDVQAMEDFL-UHFFFAOYSA-N 3-methoxy-2-phenylchromen-4-one Chemical compound O1C2=CC=CC=C2C(=O)C(OC)=C1C1=CC=CC=C1 ZAIANDVQAMEDFL-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 235000006491 Acacia senegal Nutrition 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 241000234299 Zingiberaceae Species 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000002744 anti-aggregatory effect Effects 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- SXDBWCPKPHAZSM-UHFFFAOYSA-N bromic acid Chemical compound OBr(=O)=O SXDBWCPKPHAZSM-UHFFFAOYSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229940037769 calcium carbonate 100 mg Drugs 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- 235000012241 calcium silicate Nutrition 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 235000013574 canned fruits Nutrition 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 229940069647 citric acid 1000 mg Drugs 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 229940095079 dicalcium phosphate anhydrous Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 235000013611 frozen food Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910000358 iron sulfate Inorganic materials 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 235000013310 margarine Nutrition 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- YEHDMSUNJUONMW-UHFFFAOYSA-N methoxyflavone Natural products COC1=CC=CC=C1C1=CC(=O)C2=CC=CC=C2O1 YEHDMSUNJUONMW-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- 235000019691 monocalcium phosphate Nutrition 0.000 description 1
- 229940126619 mouse monoclonal antibody Drugs 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 239000003009 skin protective agent Substances 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000004071 soot Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000012089 stop solution Substances 0.000 description 1
- 235000021012 strawberries Nutrition 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000003746 surface roughness Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- ULSUXBXHSYSGDT-UHFFFAOYSA-N tangeretin Chemical compound C1=CC(OC)=CC=C1C1=CC(=O)C2=C(OC)C(OC)=C(OC)C(OC)=C2O1 ULSUXBXHSYSGDT-UHFFFAOYSA-N 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940033203 vitamin b6 0.5 mg Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/48—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
- A23G4/068—Chewing gum characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/03—Organic compounds
- A23L29/035—Organic compounds containing oxygen as heteroatom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Dermatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Birds (AREA)
- Nutrition Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
0.01乃至10重量%範囲で含有することができる(残量は担体でもある)。
物の用途を提供する。
ケンペリアパービフロラエタノール抽出物の製造
ケンペリアパービフロラの根茎をミキサーで粉砕し、粉砕したケンペリアパービフロラ試料100gをエタノール1Lに入れて、48時間常温で冷浸して抽出した。抽出された試料はワットマン(Whatman)ろ紙(Whatman No2)で濾過し、濾過された抽出液を真空回転濃縮機で濃縮して溶媒成分を除去してケンペリアパービフロラエタノール抽出物を得た。
5,7-ジメトキシフラボン分離および構造決定
2-1. 5,7-ジメトキシフラボン分離
前記実施例1から得た濃縮されたケンペリアパービフロラエタノール抽出物を、シリカゲルを6×15cmで充填したカラムに積載し、エチルアセテートおよびメタノールを10:0.5(v/v)の比で混合した溶媒システムを利用して分取した。前記分取順により全5分画に分けてそれぞれの分画を濃縮乾燥した。5分画のうち3番目の分画(分画3)をRp-18カラムクロマトグラフィ(Lichroprep(登録商標) RP-18 25〜40μm、Merck & Co.,米国)を利用して全開溶媒70%のメタノールで分取した。前記分取順によって全2分画に分けて濃縮乾燥した。前記2分画のうち2番目の分画(分画3-2)をシリカゲルを、6×15cmで充填したカラムに積載し、エチルアセテートおよびメタノールを10:0.4(v/v)の比で混合した溶媒システムを利用して分取して最終的に前記2分画のうち、1番目の分画(分画3-2-1)を濃縮乾燥させて純粋な皮膚の皺改善、活性物質を分離して分離過程を図1に示した。
前記2−1から分離された単一活性物質の構造決定のために、1H-NMRスペクトルと13C-NMRスペクトルをそれぞれ500MHzと125MHz(溶媒:CDCl3)から測定した。収得された1H-NMRスペクトルと13C-NMRスペクトルの結果は、図2と図3に示した。前記分離された単一物質の質量分析のため、測定したEI/MSの結果を図4に示した。本化合物はEI/MSから[M]が、m/z282から観測されて分子量が282に判明された。以上の1H-NMR、13C-NMR、及びEI/MSに対する結果と既に発表された研究報告(Sutthanut K.et al.,J.Chromatography A,2007:143:227-233)を比較分析して同定した結果、前記で分離された単一物質は、下記化学式1で示される5,7-ジメトキシフラボンであることが確認された。
5,7,4'-トリメトキシフラボンの分離及び構造決定
3−1.5,7,4'-トリメトキシフラボンの分離
前記実施例1から得た濃縮されたケンペリアパービフロラエタノール抽出物を、シリカゲルを6×15cmで充填したカラムに積載して、エチルアセテート、メタノールを10:0.5(v/v)の比で混合した溶媒システムを利用して分取した。前記分取順により、全5分画に分けてそれぞれの分画を濃縮乾燥した。5分画のうち4番目の分画(分画4)をRp-18カラムクロマトグラフィ (Lichroprep(登録商標) RP-18 25〜40μm、Merck & Co.,米国)を利用して全開溶媒70%メタノールで分取した。前記分取した順によって全2分画に分けて濃縮乾燥した。最終的に2番目の分画(分画4−2)を濃縮乾燥させて、純粋な皮膚の皺改善の活性物質を分離し、その過程を図1に示した。
前記3−1で分離された単一活性物質の構造決定のために、1H-NMRスペクトルと13C-NMRスペクトルを、それぞれ500MHzと125MHz(溶媒 :CDCl3)から測定した。収得された1H-NMRスペクトルと13C-NMRスペクトルの結果は、図5と図6に示した。前記分離された単一物質の質量分析のために、測定したEI/MSの結果を図7に示した。本化合物はEI/MSから[M]が、m/z312から観測されて分子量が312に判明された。以上の1H-NMR、13C-NMR、及びEI/MSに対する結果と既に発表された研究報告(Sutthanut K.et al.,J.Chromatography A,2007:143:227-233)を比較分析して同定した結果、前記で分離された単一物質は、下記化学式2で示される5,7,4'-トリメトキシフラボンであることが確認された。
3,5,7,4'-ペンタメトキシフラボンの分離および構造決定
4−1. 3,5,7,4'-ペンタメトキシフラボンの分離
前記実施例1から得た濃縮されたケンペリアパービフロラエタノール抽出物を、シリカゲルを6×15cmに充填したカラムに積載し、エチルアセテートおよびメタノールを10:0.5(v/v)の比で混合した溶媒システムを利用して分取した。前記分取順により全5分画に分けてそれぞれの分画を濃縮乾燥した。5分画のうち3番目の分画(分画3)をRp-18カラムクロマトグラフィ(Lichroprep(登録商標)―RP-18 25〜40μm、Merck & Co.,米国)を利用して全開溶媒70%のメタノールで分取した。70%メタノールを全開溶媒に利用して分取した。前記分取順によって全2分画に分けて濃縮乾燥した。最終的に1番目の分画(分画3−1)を濃縮乾燥させて、純粋な皮膚の皺改善の活性物質を分離し、その過程を図1に示した。
前記4−1で分離された単一活性物質の質量分析のために、1H-NMRスペクトルと13C-NMRスペクトルを、それぞれ500MHzと125MHz(溶媒:CDCl3)から測定した。収得された1H-NMRスペクトルと13C-NMRスペクトルの結果は、図8と図9に示した。
UVで誘導されたコラーゲン分解酵素ー1抑制測定試験
前記実施例1−4を通じて得た5,7-ジメトキシフラボン、5,7,4'-トリメトキシフラボン、3,5,7,3',4'-ペンタメトキシフラボン、またはケンペリアパービフロラエタノール抽出物のコラーゲン分解酵素ー1抑制効能を測定した。
コラーゲン生成増進効能実験
前記実施例1−4を通じて得た、5,7ジメトキトフラボン、5,7,4'-トリメトキシフラボン、3,5,7,3',4'-ペンタメトキシフラボン、またはケンペリアパービフロラエタノール抽出物に対してコラーゲン生成増進効能を測定した。
UVから誘導された皺に対する生体内(In vivo)の皺改善効果実験
6週齢の雌無毛マウス(Hos:HR-1)48匹を1週間飼い慣して無作為で各群当り、8匹ずつ6群に分けた。無毛マウスは8週間紫外線に露出させた。この際、紫外線の照射量は1週間に3回ずつそれぞれ1MED(1MED=50 mJ/cm2)ずつ照射して4MEDまで増加させ、試験終了まで維持した。試験群は紫外線無処理群、紫外線処理群、紫外線+5,7-ジメトキシフラボン(1 mM)処理群、紫外線+5,7,4'-トリメトキシフラボン(1 mM)処理群、紫外線+3,5,7,3’,4’-ペンタメトキシフラボン(1 mM)処理群、紫外線+ケンペリアパービフロラエタノール抽出物(0.1%)処理群など、全6群とした。それぞれの試料はエタノール:ポリエチレングリコール(7:3 v/v)に溶解させて8週間毎日50μlずつ背の部位に塗布し、紫外線無処理群と紫外線処理群は、エタノール:ポリエチレングリコール(7:3 v/v)を50μlずつ塗布した。皺生成予防効果を調べるために、シリコンポリマ(SILFLO Impresston Material、Flexico England)を利用して皮膚鋳型を採取した。採取した皮膚鋳型はイメージファイルで貯蔵された皺の影の明暗をコンピュータ映像分析システムであるSkin Visipmeter SV 600ソフトウェア(Courage+Khazaha Elecronic,Kin,ドイツ)を利用してRt(皮膚表面の最高値と低値間の距離)、Rm(5部位の測定値のうちRtの最高値)、Rz(5部位の測定値Rtの平均)、Ra(算術平均表面粗度値)を測定してその結果を図12および図13に示した。
前記実施例7−1の紫外線に露出された無毛マウスに、5,7-ジメトキシフラボン(50mg/kg/day)、5,7,4'-トリメトキシフラボン(50mg/kg/day)、3,5,7,3’,4’-ペンタメトキシフラボン(50mg/kg/day)または、ケンペリアパービフロラエタノール抽出物(200mg/kg/day)をTween 80が5%含まれた0.5%カルボキシメチルセルロース溶液に溶解させて8週間毎日経口で繰返し投与した。この際、対照群である紫外線無処理群と紫外線処理群は、0.5%のカルボキシメチルセルロース溶液を投与した。投与後皺生成予防効果を調べるために、シリコンポリマ(SILFLO impression material,Flexico.England)を利用して皮膚鋳型を採取した。採取した皮膚鋳型はイメージファイルで貯蔵された皺影の明暗映像をコンピューター映像分析システムであるSkin Visiometer SV 600ソフトウェア(Courage+Khazaha Elecronic,Kin,ドイツ)を利用して、Rt,Rm,Rz,Raを測定し、その結果を図14および図15に示した。
UVから誘導された表皮水分損失量改善実験
前記実施例1ー4を通じて得た、5,7-ジメトキシフラボン、5,7,4'-トリメトキシフラボン、3,5,7,3’,4’-ペンタメトキシフラボンまたはケンペリアパービフロラエタノール抽出物の表皮水分損失量改善効能を測定した。
前記実施例7−1の無毛マウスの背部位の皮膚からTewameter(TM300,Courage+Khazaha Elecronic,Kin,ドイツ)を利用して表皮の水分損失量を測定した。
前記実施例7−2の無毛マウスの背部位の皮膚からTewameterを利用して表皮の水分損失量を測定した。
皮膚弾力度改善実験
前記実施例1ー4を通じて得た、5,7-ジメトキシフラボン、5,7,4'-トリメトキシフラボン、3,5,7,3’,4’-ペンタメトキシフラボン、またはケンペリアパービフロラエタノール抽出物の皮膚弾力改善効能を測定した。
前記実施例7−1の無毛マウスの背部位の皮膚からCutometerを利用して皮膚の弾力度改善を測定して紫外線無処理群と比較した。
前記実施例7−2の無毛マウスの背部位の皮膚からCutometerを利用して皮膚の弾力度改善を測定して紫外線無処理群と比較した。
1-1〜1-4、栄養化粧水(ミルクローション)
前記実施例1−4のケンペリアパービフロラエタノール抽出物または、5,7-ジメトキシフラボン、5,7,4'-トリメトキシフラボン、3,5,7,3’,4’-ペンタメトキシフラボンを、下記表6の栄養化粧水製剤比率通りにして一般的な方法で栄養化粧水を製造した。
前記実施例1−4のケンペリアパービフロラエタノール抽出物、または5,7-ジメトキシフラボン、5,7,4'-トリメトキシフラボン、3,5,7,3’,4’-ペンタメトキシフラボンを、下記表7の柔軟化粧水製剤比率と同じくして、一般的な方法により柔軟化粧水を製造した。
前記実施例1−4のケンペリアパービフロラエタノール抽出物、または5,7-ジメトキシフラボン、5,7,4'-トリメトキシフラボン、3,5,7,3’,4’-ペンタメトキシフラボンを下記表8の栄養クリーム製剤比率と同じく一般的な方法により栄養クリームを製造した。
前記実施例1−4のケンペリアパービフロラエタノール抽出物、または5,7-ジメトキシフラボン、5,7,4'-トリメトキシフラボン、3,5,7,3’,4’-ペンタメトキシフラボンを下記表9のマッサージクリーム製剤比率と同じく一般的な方法によりマッサージクリームを製造した。
前記実施例1−4のケンペリアパービフロラエタノール抽出物、または5,7-ジメトキシフラボン、5,7,4'-トリメトキシフラボン、3,5,7,3’,4’-ペンタメトキシフラボンを下記表10のパック製剤比率と同じく一般的な方法によりパックを製造した。
前記実施例1−4のケンペリアパービフロラエタノール抽出物、または5,7-ジメトキシフラボン、5,7,4'-トリメトキシフラボン、3,5,7,3’,4’-ペンタメトキシフラボンを下記表11のゲル製剤比率と同じく一般的な方法によりゲルを製造した。
2−1.健康食品の製造
前記実施例1−4のケンペリアパビフロラエタノール抽出物、または5,7-ジメトキシフラボン、5,7,4'-トリメトキシフラボン、3,5,7,3’,4’-ペンタメトキシフラボン1000 mg、ビタミンAアセテート70μg、ビタミンE 1.0mg、ビタミンB1 0.13mg、ビタミンB2 0.15mg、ビタミンB6 0.5mg、ビタミンB12 0,2mg、ビタミンC 10mg、ビオチン 10μg、ニコチン酸アミド 1.7 mg、葉酸 50μg、パントテン酸カルシウム 0.5mg、硫酸鉄1鉄 1.75 mg、酸化亜鉛 0.82mg、炭酸マグネシウム 25.3 mg、第1リン酸カルリウム 15mg、第2リン酸カルシウム 55mg、クエン酸カリウム 90 mg、炭酸カルシウム 100 mg、塩化マグネシウム24.8 mgを混合して製造することができ、その配合比を変形してもよく、通常の健康食品製造方法により、前記の成分を混合した後、顆粒を製造し、通常の方法により健康食品組成物製造に使用することができる。
前記実施例1−4のケンペリアパービフロラエタノール抽出物、または5,7-ジメトキシフラボン、5,7,4'-トリメトキシフラボン、3,5,7,3’,4’-ペンタメトキシフラボン1000 mg、クエン酸1000mg、オリゴ糖 100g、梅実濃縮液 2g、タウリン 1gに精製水を加えて、全900mlを通常の健康飲料製造方法により、前記の成分を混合して約1時間85℃で撹拌加熱した後、出来上がった溶液を濾過して、滅菌された2L容器に取得して密封滅菌して冷蔵保管した後、健康飲料組成物製造に使用することができる。
ガムベース20重量%、砂糖76.9重量%、香料1重量%および水2重量%と、前記実施例1−4のケンペリアパービフロラエタノール抽出物、または5,7-ジメトキシフラボン、5,7,4'-トリメトキシフラボン、3,5,7,3’,4’-ペンタメトキシフラボン0.1重量%を配合して通常の方法によりチューインガムを製造した。
砂糖60重量%、水飴39.8重量%、および香料0.1重量%と、前記実施例1−4のケンペリアパービフロラエタノール抽出物、または5,7-ジメトキシフラボン、5,7,4'-トリメトキシフラボン、3,5,7,3’,4’-ペンタメトキシフラボン0.1重量%を配合して通常の方法によりキャンデーを製造した。
薄力粉1級25.59重量%、中力粉1級22.22重量%、精白糖4.80重量%、食塩0.73重量%、ブドウ糖0.78重量%パームショートニング11.78重量%、アンモニウム1.54重量%、重曹0.17重量%、重亜硫酸ナトリウム0.16重量%、米粉1.45重量%、ビタミンB0.0001重量%、ミルク香0.04重量%、水20.6998重量%、全脂粉乳1.16重量%、代用粉乳0.29重量%、第1リン酸カルシウム0.03重量%、撒布塩0.29重量%および噴霧油7.27重量%と、前記実施例1−4のケンペリアパービフロラエタノール抽出物、または5,7-ジメトキシフラボン、5,7,4'-トリメトキシフラボン、3,5,7,3’,4’-ペンタメトキシフラボン1重量%を配合して通常の方法によりビスケットを製造した。
3−1.散剤
前記実施例1−4のケンペリアパービフロラエタノール抽出物、または5,7-ジメトキシフラボン、5,7,4'-トリメトキシフラボン、3,5,7,3’,4’-ペンタメトキシフラボン50mg、結晶セルロース2gを混合して通常の製造方法により気密布に充填して散剤を製造した。
前記実施例1−4のケンペリアパービフロラエタノール抽出物、または5,7-ジメトキシフラボン、5,7,4'-トリメトキシフラボン、3,5,7,3’,4’-ペンタメトキシフラボン50mg、結晶セルロース400mg、ステアリン酸マグネシウム5mgを混合して通常の錠剤製造方法により打錠して錠剤を製造した。
前記実施例1−4のケンペリアパービフロラエタノール抽出物、または5,7-ジメトキシフラボン、5,7,4'-トリメトキシフラボン、3,5,7,3’,4’-ペンタメトキシフラボン30mg、乳清蛋白質100mg、結晶セルロース400mg、ステアリン酸マグネシウム6mgを混合して通常のカプセル剤製造方法によりゼラチンカプセルに充填してカプセル剤を製造した。
通常の注射剤製造方法により、活性成分を注射用蒸留水に溶解してpHを約7.5に調節して、前記実施例1−4のケンペリアパービフロラエタノール抽出物、または5,7-ジメトキシフラボン、5,7,4'-トリメトキシフラボン、3,5,7,3’,4’-ペンタメトキシフラボン100mg、注射用蒸留水、pH調節剤を混合して2ml容量のアンプルに充填して滅菌させて注射剤を製造した。
Claims (20)
- ケンペリアパービフロラ抽出物を有効成分として含む、皺改善、抗老化及び皮膚弾力増進用化粧料組成物。
- ケンペリアパービフロラ抽出物を有効成分として含む、皺改善、抗老化及び皮膚弾力増進用食品組成物。
- ケンペリアパービフロラ抽出物を有効成分として含む、皺改善、抗老化及び皮膚弾力増進用薬学的組成物。
- ケンペリアパービフロラ抽出物を有効成分として含む、皮膚保湿用化粧料組成物。
- ケンペリアパービフロラ抽出物を有効成分として含む、皮膚保湿用食品組成物。
- 前記ケンペリアパービフロラ抽出物は、水、炭素数1−6個の有機溶媒および亜臨界または超臨界流体から選ばれた1つ以上の溶媒による抽出物であることを特徴とする、請求項6乃至請求項10の内いずれか1つの項に記載の組成物。
- 前記炭素数1−6個の有機溶媒は、炭素数1−6個のアルコール、アセトン、エーテル、ベンゼン、クロロホルム、エチルアセテート、メチレンクロライド、ヘキサン、シクロヘキサンおよび石油エテルから選ばれたことを特徴とする請求項11記載の組成物。
- ケンペリアパービフロラ抽出物の皺改善、抗老化及び皮膚弾力増進剤製造のための使用。
- ケンペリアパービフロラ抽出物を、これを必要とする個体に有効量で投与または塗布することを特徴とする皺改善、抗老化及び皮膚弾力増進方法。
- ケンペリアパービフロラ抽出物の皮膚保湿剤製造のための使用。
- ケンペリアパービフロラ抽出物を、これを必要とする個体に有効量で投与または塗布することを特徴とする皮膚保湿方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2011-0006338 | 2011-01-21 | ||
KR20110006338 | 2011-01-21 | ||
PCT/KR2012/000601 WO2012099449A2 (ko) | 2011-01-21 | 2012-01-25 | 플라본계 화합물의 신규한 용도 |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2014508139A true JP2014508139A (ja) | 2014-04-03 |
Family
ID=46516278
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013550414A Pending JP2014508139A (ja) | 2011-01-21 | 2012-01-25 | フラボン系化合物の新規な用途 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20140148504A1 (ja) |
JP (1) | JP2014508139A (ja) |
KR (1) | KR101434653B1 (ja) |
CN (1) | CN103547250A (ja) |
WO (1) | WO2012099449A2 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2017088616A (ja) * | 2017-02-09 | 2017-05-25 | 株式会社東洋新薬 | 黒生姜含有組成物 |
JP2017178889A (ja) * | 2016-03-31 | 2017-10-05 | チズBeファクトリー株式会社 | Oph活性増強剤 |
JP7412743B2 (ja) | 2019-07-31 | 2024-01-15 | 株式会社常磐植物化学研究所 | 涙液量改善用組成物、便秘改善用組成物、及び、肌質改善用組成物。 |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2799081A4 (en) * | 2011-12-27 | 2015-06-24 | Tokiwa Phytochemical Co Ltd | SIRTUIN ACTIVATOR |
JP6010482B2 (ja) * | 2013-02-27 | 2016-10-19 | 株式会社東洋新薬 | 経口用組成物 |
JP2015027998A (ja) * | 2013-06-24 | 2015-02-12 | 株式会社東洋新薬 | 保湿剤、皮膚バリア機能改善剤、タイトジャンクション形成促進剤、trpv4発現上昇剤、細胞内カルシウム濃度上昇剤、細胞内カルシウム濃度上昇剤、脂質合成促進剤、血流改善剤及びクマ改善剤 |
SG10201808943RA (en) * | 2014-05-09 | 2018-11-29 | Suntory Holdings Ltd | Fat or oil extract of black ginger and method for producing same |
JP6241631B2 (ja) * | 2016-09-13 | 2017-12-06 | 株式会社東洋新薬 | 経口用組成物 |
KR20190025464A (ko) | 2017-09-01 | 2019-03-11 | 선문대학교 산학협력단 | 크리신 유도체 및 이를 포함하는 화장료 조성물 |
JP6518744B2 (ja) * | 2017-10-23 | 2019-05-22 | 株式会社東洋新薬 | 経口用組成物 |
WO2020086820A1 (en) | 2018-10-26 | 2020-04-30 | Galanin Ivan | Topical compositions and methods to promote optimal dermal white adipose tissue composition in vivo |
JP2019142923A (ja) * | 2019-04-22 | 2019-08-29 | 株式会社東洋新薬 | 経口用組成物 |
KR102453894B1 (ko) * | 2020-09-15 | 2022-10-11 | (주)아모레퍼시픽 | 캄페롤 배당체 화합물을 포함하는 피부 보호용 조성물 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009051790A (ja) * | 2007-08-29 | 2009-03-12 | Maruzen Pharmaceut Co Ltd | 抗酸化剤、抗老化剤、抗炎症剤、育毛剤、抗肥満剤、及び美白剤、並びに化粧料及び美容用飲食品 |
JP2011236133A (ja) * | 2010-05-06 | 2011-11-24 | Nippon Tablet Kk | キサンチンオキシダーゼ阻害剤、キサンチンオキシダーゼ阻害活性及び5α−レダクターゼ阻害活性を有する酵素阻害剤、並びに該酵素阻害剤を含有する飲食品類、化粧料組成物、医薬組成物 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08157346A (ja) * | 1994-12-07 | 1996-06-18 | Shiseido Co Ltd | 紫外線吸収性皮膚化粧料 |
AU778128B2 (en) * | 2000-04-19 | 2004-11-18 | Nof Corporation | Cosmetic composition |
KR20040107713A (ko) * | 2003-06-10 | 2004-12-23 | 대한민국 (부경대학교총장) | 황금 추출물 또는 이로부터 분리한 바이칼린, 바이칼레인,우고닌 또는 5,7,2,5-테트라하이드록시-8,6-디메톡시플라본을 함유하는 노화 방지 및 억제용 약학조성물 |
CN100415731C (zh) * | 2004-12-30 | 2008-09-03 | 财团法人工业技术研究院 | 治疗b型肝炎的化合物及其医药组合物 |
JP2009067731A (ja) * | 2007-09-14 | 2009-04-02 | Office K:Kk | 冷え性改善用組成物 |
JP2011500669A (ja) * | 2007-10-17 | 2011-01-06 | ニュートゥリー カンパニー リミテッド | パンドラチン誘導体またはこれを含有するケンフェリアパンドラタ抽出物の新規な用途 |
JP6309184B2 (ja) * | 2007-11-15 | 2018-04-11 | ザ ジェネラル ホスピタル コーポレイション | 皮膚損傷の減少のための方法、及び組成物 |
-
2012
- 2012-01-25 CN CN201280014200.1A patent/CN103547250A/zh active Pending
- 2012-01-25 WO PCT/KR2012/000601 patent/WO2012099449A2/ko active Application Filing
- 2012-01-25 KR KR1020120007460A patent/KR101434653B1/ko active IP Right Grant
- 2012-01-25 JP JP2013550414A patent/JP2014508139A/ja active Pending
-
2013
- 2013-07-19 US US13/946,609 patent/US20140148504A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009051790A (ja) * | 2007-08-29 | 2009-03-12 | Maruzen Pharmaceut Co Ltd | 抗酸化剤、抗老化剤、抗炎症剤、育毛剤、抗肥満剤、及び美白剤、並びに化粧料及び美容用飲食品 |
JP2011236133A (ja) * | 2010-05-06 | 2011-11-24 | Nippon Tablet Kk | キサンチンオキシダーゼ阻害剤、キサンチンオキシダーゼ阻害活性及び5α−レダクターゼ阻害活性を有する酵素阻害剤、並びに該酵素阻害剤を含有する飲食品類、化粧料組成物、医薬組成物 |
Non-Patent Citations (1)
Title |
---|
JPN6015001759; K.Sutthanut et.al.: 'Simultaneous identification and quantitation of 11 flavonoid constituents in Kaempferia parviflora b' Journal of Chromatography A 1143(2007), 20070113, 227-233 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2017178889A (ja) * | 2016-03-31 | 2017-10-05 | チズBeファクトリー株式会社 | Oph活性増強剤 |
JP2017088616A (ja) * | 2017-02-09 | 2017-05-25 | 株式会社東洋新薬 | 黒生姜含有組成物 |
JP7412743B2 (ja) | 2019-07-31 | 2024-01-15 | 株式会社常磐植物化学研究所 | 涙液量改善用組成物、便秘改善用組成物、及び、肌質改善用組成物。 |
Also Published As
Publication number | Publication date |
---|---|
KR20120085216A (ko) | 2012-07-31 |
WO2012099449A3 (ko) | 2012-12-06 |
CN103547250A (zh) | 2014-01-29 |
WO2012099449A2 (ko) | 2012-07-26 |
US20140148504A1 (en) | 2014-05-29 |
KR101434653B1 (ko) | 2014-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101434653B1 (ko) | 플라본계 화합물의 신규한 용도 | |
KR101841255B1 (ko) | 피부주름 개선 및 탄력 증진용 조성물 | |
KR102239121B1 (ko) | 당 비함유 파인애플 추출물과 그 제조 방법 및 그 용도 | |
JP6474418B2 (ja) | フコステロールを含有する皮膚美白又は皮膚保湿用組成物 | |
JP2009126863A (ja) | キノコから抽出したエルゴチオネインを高含有する組成物 | |
US20160271028A1 (en) | Novel use of panduratin derivatives or extract of kaempferia pandurata comprising the same | |
JP5027361B2 (ja) | ヒアルロン酸産生促進剤 | |
TW200401780A (en) | Novel derivative of flavone C-glycoside and composition containing the same | |
KR101914441B1 (ko) | 퓨코스테롤을 유효성분으로 포함하는 피부 보습용 화장료 조성물 | |
KR101904501B1 (ko) | 퓨코스테롤을 유효성분으로 포함하는 피부주름 개선 또는 피부탄력 증진용 화장료 조성물 | |
JP6456032B2 (ja) | Sirt1活性化剤および当該Sirt1活性化剤の利用 | |
KR101830395B1 (ko) | 스쿠알렌을 함유하는 근기능 향상 및 근육 손상 예방용 조성물 | |
JP2003176230A (ja) | コラーゲン産生促進剤、エラスターゼ阻害剤、コラゲナーゼ阻害剤及び皮膚化粧料並びに美容用飲食品 | |
KR20150113709A (ko) | 삼채 추출물을 유효성분으로 함유하는 피부 미백용 조성물 | |
JP2019520786A (ja) | 3−o−ガロイル−3,3’,5,5’,7−ペンタヒドロキシフラボンを含む保湿用組成物 | |
US11197878B2 (en) | Anti-inflammatory composition including novel quercetin-based compound | |
KR20170080084A (ko) | 네포딘을 포함하는 피부상태 개선용 조성물 | |
KR20230096823A (ko) | 황새냉이 추출물을 유효성분으로 함유하는 피부질환의 예방, 개선 또는 치료용 조성물 | |
AU2020260940A2 (en) | Composition comprising Actinidia polygama extract for alleviating skin damage or moisturizing skin | |
KR102138263B1 (ko) | 피부 재생 또는 주름 개선용 조성물 | |
KR20170076418A (ko) | 딕탐닌을 포함하는 피부상태 개선용 조성물 | |
JP2010275245A (ja) | 活性酸素起因障害抑制剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20140121 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20150113 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150127 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20150424 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20150526 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20150626 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150727 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20160112 |